Daniel S. Goldman sold GSK (Glaxosmithkline PLC) on Jul 10, 2023 with an estimated value between $15,000 and $50,000. This trade was filed under undisclosed. The stock is currently up 67.5% from the trade price.

Daniel S. Goldman

Democrat· house

New York

GSK

Glaxosmithkline PLC

Health Care

Trade Details

Transaction

Sale

Trade Date

Jul 10, 2023(2 years ago)

Disclosed

Aug 14, 202335d gap

Owner

undisclosed

Estimated Value

$15,000 – $50,000

Trade Price

$33.85

Price Today

$56.69

Return (if held)

+67.5%

Daniel S. Goldman sold $GSK at $33.85 on Jul 10, 2023

Price Change Since Trade

+67.5%